The new tablets match Xigduo XR and are available in four strengths: 5 mg/500 mg, 5 mg/1,000 mg, 10 mg/500 mg, and 10 mg/1,000 mg.
By expanding its diabetes lineup with cost-friendly choices, Lupin is aiming to make treatment more accessible for patients requiring combination therapy for blood sugar control.
